Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report

Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report

Abstract Fixed dosage regimen is currently the standard therapy with tyrosine kinase inhibitors (TKI). This case report demonstrates successful determination of nilotinib dosage by therapeutic drug monitoring (TDM) in a patient with chronic myeloid leukemia (CML). TDM may provide useful marker for i...

Full description

Bibliographic Details
Main Authors: Ryosuke Nakahara, Takahiro Sumimoto, Masao Ogata, Yuhki Sato, Hiroki Itoh
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Clinical Case Reports
Subjects:
chronic myeloid leukemia
hepatic dysfunction
nilotinib
therapeutic drug monitoring
Online Access:https://doi.org/10.1002/ccr3.2191

Internet

https://doi.org/10.1002/ccr3.2191

Similar Items